Comparer des méthodes

	Plan expérimental croisé avec groupe témoin	Conception expérimentale avec groupe témoin
Domaine	Plans d'expériences	Plans d'expériences
Famille	Process / pipeline	Process / pipeline
Année d'origine	Mid-20th century; systematic treatment from 1980s onward	1935 (Fisher); 1963 (Campbell & Stanley codification)
Auteur d'origine	Established in clinical pharmacology and agricultural research; formalized by B. Jones & M. G. Kenward	Ronald A. Fisher; systematised by Donald T. Campbell & Julian C. Stanley
Type	Experimental design	Experimental research design
Source fondatrice	Jones, B., & Kenward, M. G. (2003). Design and Analysis of Cross-Over Trials (2nd ed.). Chapman and Hall/CRC. ISBN: 978-1584883500	Campbell, D. T., & Stanley, J. C. (1963). Experimental and Quasi-Experimental Designs for Research. Rand McNally.
Alias	crossover controlled trial, within-subject crossover with control, AB/BA crossover controlled design, repeated-measures crossover with control arm	controlled experiment, true experimental design, randomized controlled design, treatment-control design
Apparentées	6	4
Résumé	A crossover control group experimental design is an experimental approach in which participants are randomly assigned to sequences of conditions that include both a treatment and a control (no-treatment or placebo) period, with each participant experiencing both the experimental and control conditions in succession. By using each participant as their own control across periods, this design sharply reduces between-subject variability and typically requires fewer participants than parallel group trials to achieve equivalent statistical power.	Control group experimental design is a fundamental experimental structure in which participants are assigned to at least two groups — a treatment group that receives the intervention and a control group that does not — so that the effect of the intervention can be isolated by comparing outcomes across groups. Randomisation of assignment strengthens causal inference by balancing known and unknown confounders.